Previous Close | 0.7000 |
Open | 0.6968 |
Bid | 0.6535 x 100 |
Ask | 0.7232 x 100 |
Day's Range | 0.6801 - 0.7100 |
52 Week Range | 0.4500 - 1.4400 |
Volume | |
Avg. Volume | 167,448 |
Market Cap | 34.977M |
Beta (5Y Monthly) | 1.16 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Evogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call Transcript March 7, 2024 Evogene Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Welcome to Evogene’s Fourth Quarter and Full Year 2023 Results Conference […]
Evogene (EVGN) delivered earnings and revenue surprises of 7.14% and 66.59%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Does Evogene (EVGN) have what it takes to be a top stock pick for momentum investors? Let's find out.